200 results
8-K
EX-99.1
LSTA
Lisata Therapeutics Inc
29 Feb 24
Lisata Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
4:09pm
offset by severance costs associated with the elimination of the Chief Business Officer position on May 1, 2023.
Overall, net losses were $20.8 million
8-K
EX-99.1
LSTA
Lisata Therapeutics Inc
14 Aug 23
Lisata Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
4:08pm
with the elimination of the Chief Business Officer position on May 1, 2023, partially offset by non-recurring merger related costs in the prior year.
Overall, net
8-K
EX-99.1
blvycgnf
9 May 23
Lisata Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
4:08pm
8-K
EX-99.1
18k4cu0wetaez1htf8
30 Mar 23
Lisata Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
4:07pm
8-K
EX-99.1
15mp0q5x9r3 09gw
10 Nov 22
Lisata Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
4:10pm
8-K/A
EX-99.3
8qntx
4 Oct 22
Other Events
4:42pm
8-K/A
EX-99.2
d3nshbl 7uvfk
4 Oct 22
Other Events
4:42pm
424B3
gwnhnimpr
29 Jul 22
Prospectus supplement
4:06pm